Compare SFBS & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SFBS | MMED |
|---|---|---|
| Founded | 2005 | 1983 |
| Country | United States | United States |
| Employees | N/A | 2800 |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.3B |
| IPO Year | 2014 | 2026 |
| Metric | SFBS | MMED |
|---|---|---|
| Price | $88.25 | $17.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $93.00 | $22.56 |
| AVG Volume (30 Days) | 289.2K | ★ 1.0M |
| Earning Date | 04-20-2026 | 06-03-2026 |
| Dividend Yield | ★ 1.94% | N/A |
| EPS Growth | ★ 21.63 | N/A |
| EPS | ★ 1.52 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $32.30 | $15.99 |
| Revenue Next Year | $10.30 | $10.00 |
| P/E Ratio | $57.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $67.20 | $10.65 |
| 52 Week High | $90.64 | $17.86 |
| Indicator | SFBS | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 58.66 | 68.77 |
| Support Level | $78.72 | $14.70 |
| Resistance Level | $88.96 | N/A |
| Average True Range (ATR) | 2.03 | 0.92 |
| MACD | -0.11 | 0.09 |
| Stochastic Oscillator | 67.76 | 95.75 |
Servisfirst Bancshares Inc is a bank holding company whose business is conducted by its wholly owned subsidiary. Through the subsidiary, it offers various banking services to individual and corporate customers in Birmingham, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. Its various products and service offerings include commercial, consumer, and other loans; accepting deposits; providing electronic banking services, such as online and mobile banking, including remote deposit capture; delivering treasury and cash management services; and providing banking services to other financial institutions. The company operates as a single reportable segment, with a majority of its revenue being derived from the business of banking.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.